Drug Type Small molecule drug |
Synonyms GSK 726701A, GSK-726701A, GSK726701A |
Target |
Action agonists |
Mechanism EP4 agonists(Prostanoid EP4 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22FNO5 |
InChIKeyYJEFCZJZEASKIO-UHFFFAOYSA-N |
CAS Registry945721-87-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pain | Preclinical | United Kingdom | 31 Mar 2018 |





